Mutations in presenilin-1 gene are responsible for the majority of early-on
set familial Alzheimer's disease casts. The function of this protein and th
e mechanism underlying the pathogenicity of its mutations are still unclear
. To elucidate the role of presenilin-1 in the Alzheimer's disease patholog
y, we tested two such mutations (P117L and M146L) for their effect in stabl
y transfected mouse neuroblastoma cell lines. Over-expression of the wild-t
ype presenilin-1 gene induced formation of a well-extended. orderly organiz
ed network consisting of neurofilaments assembled from the L and H subunits
, while in cells with the mutant gene this network was markedly reduced to
short filaments concentrated in structures resembling cups. Cells expressin
g the mutant gene displayed altered processing of the transgene protein and
neurofilament H, suggesting that presenilin-1 is the mediator of changes t
argeted at neurofilaments, The two different mutations produced similar alt
erations, implying that this is a common pathogenic mechanism. Presenilin-1
, neurofilament-H and tau proteins showed co-localization as evidenced by c
onfocal microscopy, suggesting a possible physiological connection between
these three proteins.
Presenilin-1 appears to influence assembly of the H subunit into neurofilam
ents and the subsequent formation of new neurites. Mutations impair this fu
nction of presenilin-1, resulting in inhibition of neurite outgrowth. That
presenilin-1 influences the assembly of neurofilaments may represent a nove
l pathway through which presenilin-1 mutations are involved in Alzheimer's
disease pathology. In this hypothesis, presenilin-1 mutations will be assoc
iated with aberrant sprouting leading to synaptic loss, a key neuropatholog
ical feature of Alzheimer's disease. (C) 2001 IBRO. Published by Elsevier S
cience Ltd. All rights reserved.